Anti-neutrophil cytoplasmic antibody-associated pauci-immune crescentic glomerulonephritis complicating Sjögren's syndrome

Journal of the Formosan Medical Association

Volumn 110, Issue 7, 2011, Pages 473-477

  Wang, Wei Jei ^a   Wu, Hau Shin ^a   Chu, Tzong Shinn ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti neutrophil cytoplasmic antibodies; Crescentic glomerulonephritis; Sj gren's syndrome

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; LA ANTIBODY; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RO ANTIBODY;

AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CREATININE BLOOD LEVEL; DECREASED APPETITE; DISEASE SEVERITY; HEMATURIA; HEMIPLEGIA; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; LABORATORY TEST; MALE; MICROSCOPIC HEMATURIA; NEPHROLITHIASIS; PHYSICAL EXAMINATION; PLASMAPHERESIS; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RECURRENT FEVER; RENOGRAPHY; SALIVARY GLAND DISEASE; SEPSIS; SJOEGREN SYNDROME; TREATMENT OUTCOME; URINALYSIS; WEIGHT REDUCTION;

EID: 79960762373     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(11)60070-3     Document Type: Article

References (12)

1. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
2. Schmitt WH, van der Woude FJ. Clinical applications of antineutrophil cytoplasmic antibody testing. Curr Opin Rheumatol 2004;16:9-17.
3. Luxton G, Langham R, Caring for Australians with Renal Impairment (CARI). The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis. Nephrology (Carlton) 2008;13(Suppl 2): S17-23.
4. Ramos-Casals M, Nardi N, Brito-Zerón P, et al. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum 2006;35:312-21.
5. Nishiya K, Chikazawa H, Hashimoto K, et al. Antineutrophil cytoplasmic antibody in patients with primary Sjögren's syndrome. Clin Rheumatol 1999;18:268-71.
6. Skopouli FN. Kidney injury in Sjögren's syndrome. Nephrol Dial Transplant 2001;16(Suppl 6):63-4.
7. Dussol B, Tsimaratos M, Bolla G, et al. Crescentic glomerulonephritis and primary Gougerot-Sjögren syndrome. Nephrologie 1994;15:295-8.
8. Hernández JL, Rodrigo E, De Francisco AL, et al. ANCAassociated pauci-immune crescentic glomerulonephritis complicating Sjögren's syndrome. Nephrol Dial Transplant 1996;11:2313-5.
9. Kamachi M, Migita K, Tominaga M, et al. Sjögren's syndrome complicated by MPO-ANCA positive crescentic glomerulonephritis. Nephrol Dial Transplant 1999;14: 1033-4.
10. Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int 2007;56:87-96.
11. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006;17:2264-74.
12. Menahem S, Hiremagalur B, Mudge D, et al. The CARI guidelines. Induction and maintenance therapy in ANCAassociated systemic vasculitis. Nephrology (Carlton) 2008; 13(Suppl 2):S24-36.